e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Interdependence of COPD and comorbidities and the underlying mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
D. Halpin (Exeter, United Kingdom), H. De Jong (Singapore, Singapore), V. Carter (Singapore, Singapore), D. Skinner (Singapore, Singapore), D. Price (Singapore, Singapore)
Source:
International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Session:
Interdependence of COPD and comorbidities and the underlying mechanisms
Session type:
Poster Discussion
Number:
3616
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Halpin (Exeter, United Kingdom), H. De Jong (Singapore, Singapore), V. Carter (Singapore, Singapore), D. Skinner (Singapore, Singapore), D. Price (Singapore, Singapore). Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population. 3616
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Application of the COMCOLD comorbidity index to a UK primary care COPD cohort
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Health status changes in Dutch regular care COPD patients classified per GOLD category
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
Disease burden in COPD patients in the first 24 months following diagnosis in a UK primary care setting
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Prevalence of asthma characteristics in COPD patients in a Dutch well-established asthma/COPD service for primary care
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019
Incidence and impact of healthcare defined exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
A survey of asthma severity, comorbidities and treatments in a paediatric primary care cohort in the UK
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Psychologic impairment according to GOLD COPD staging for patients in a primary care setting
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Characteristics and treatment patterns of newly diagnosed COPD patients in Canada
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006
Prevalence and predictors of electronic cigarette use by patients with COPD in the Birmingham COPD cohort
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1)
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
The distribution of COPD in UK general practice using the 2017 GOLD classification
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
The COPD patient’s journey - newly diagnosed COPD patients in the UK Mediplus database
Source: Eur Respir J 2004; 24: Suppl. 48, 143s
Year: 2004
Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study
Source: International Congress 2018 – COPD management
Year: 2018
Factors associated with COPD exacerbation frequency in a UK primary care cohort
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Patterns of initial treatment for COPD according to clinical phenotypes in Catalonia
Source: International Congress 2015 – COPD: notable points
Year: 2015
Description of gold-defined COPD severity stages in UK primary care
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept